A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia

A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia

Atherosclerotic cardiovascular disease (ASCVD) is the primary contributor to global mortality rates, which significantly escalates healthcare expenditures. Risk factors for ASCVD (including dyslipidemia) frequently present in clusters rather than separately. Addressing these risk factors is crucial...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine Vol. 12; no. 13; p. 4312
Main Authors: Al Mousa, Eyas, Al-Azzam, Sayer, Araydah, Mohammad, Karasneh, Reema, Ghnaimat, Mohammad, Al-Makhamreh, Hanna, Al Khawaldeh, Abdelkarim, Ali Abu Al-Samen, Muneer, Haddad, Jihad, Al Najjar, Said, Alsalaheen Abbadi, Hatem, Hammoudeh, Ayman J
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 27-06-2023
MDPI
Subjects:
Atherosclerosis
Cardiovascular disease
Care and treatment
Cholesterol
Clinical medicine
Clinical practice guidelines
Diabetes
Diagnosis
Drug therapy
Dyslipidemias
Evaluation
Fatalities
High density lipoprotein
Hypertension
Lifestyles
Lipids
Literature reviews
Medical personnel
Metabolic disorders
Obesity
Population
Practice guidelines (Medicine)
Review
Risk factors
Smoking
Statins
Jordan
Middle East
low-density lipoproteins
treatment
drugs
cholesterol
dyslipidemias
high-density lipoproteins
triglycerides
apolipoprotein B
atherosclerotic cardiovascular diseases
lifestyle
total cardiovascular risk
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Atherosclerotic cardiovascular disease (ASCVD) is the primary contributor to global mortality rates, which significantly escalates healthcare expenditures. Risk factors for ASCVD (including dyslipidemia) frequently present in clusters rather than separately. Addressing these risk factors is crucial in the early initiation of a comprehensive management plan that involves both lifestyle modifications and pharmacotherapy to reduce the impact of ASCVD. A team of Jordanian professionals from various medical organizations and institutes took the initiative to create a set of guidelines for dyslipidemia screening and therapy. A detailed, comprehensive literature review was undertaken utilizing several databases and keywords. This consensus statement provides recommendations for dyslipidemia management in Jordanians on several issues including cardiovascular risk estimation, screening eligibility, risk categories, treatment goals, lifestyle changes, and statin and non-statin therapies. It is recommended that all Jordanian individuals aged 20 years old or older undergo lipid profile testing. This should be followed by determining the level of cardiovascular risk depending on the presence or absence of ASCVD and cardiovascular risk factors, eligibility for lipid-lowering therapy, and the target low-density cholesterol serum level to be achieved. In conclusion, prioritizing the management of dyslipidemia is of the utmost importance in improving public health and reducing the burden of cardiovascular diseases.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm12134312